机构:
INSERM, UMR 1052, Grp Radiobio, Ctr Rech Canc, 28 Rue Laennec, F-69008 Lyon, FranceINSERM, UMR 1052, Grp Radiobio, Ctr Rech Canc, 28 Rue Laennec, F-69008 Lyon, France
Foray, Nicolas
[1
]
Bourguignon, Michel
论文数: 0引用数: 0
h-index: 0
机构:
IRSN, 31 Ave Div Leclerc, F-92260 Fontenay Aux Roses, FranceINSERM, UMR 1052, Grp Radiobio, Ctr Rech Canc, 28 Rue Laennec, F-69008 Lyon, France
Bourguignon, Michel
[2
]
Hamada, Nobuyuki
论文数: 0引用数: 0
h-index: 0
机构:
CRIEPI, Nucl Technol Res Lab, Radiat Safety Res Ctr, 2-11-1 Iwado Kita, Tokyo 2018511, JapanINSERM, UMR 1052, Grp Radiobio, Ctr Rech Canc, 28 Rue Laennec, F-69008 Lyon, France
Hamada, Nobuyuki
[3
]
机构:
[1] INSERM, UMR 1052, Grp Radiobio, Ctr Rech Canc, 28 Rue Laennec, F-69008 Lyon, France
[2] IRSN, 31 Ave Div Leclerc, F-92260 Fontenay Aux Roses, France
[3] CRIEPI, Nucl Technol Res Lab, Radiat Safety Res Ctr, 2-11-1 Iwado Kita, Tokyo 2018511, Japan
The human response to ionizing radiation (IR) varies among individuals. The first evidence of the individual response to IR was reported in the beginning of the 20th century. Considering nearly one century of observations, we here propose three aspects of individual IR response: radiosensitivity for early or late adverse tissue events after radiotherapy on normal tissues (non-cancer effects attributable to cell death); radiosusceptibility for IR-induced cancers; and radiodegeneration for non-cancer effects that are often attributable to mechanisms other than cell death (e.g., cataracts and circulatory disease). All the molecular and cellular mechanisms behind IR-induced individual effects are not fully elucidated. However, some specific assays may help their quantification according to the dose and to the genetic status. Accumulated data on individual factors have suggested that the individual IR response cannot be ignored and raises some clinical and societal issues. The individual IR response therefore needs to be taken into account to better evaluate the risks related to IR exposure. (C) 2016 Elsevier B.V. All rights reserved.